Cipher Pharmaceuticals, Inc. (CPH.TO)
14.17
+0.56
(+4.11%)
CAD |
TSX |
Nov 13, 16:00
Cipher Pharmaceuticals Market Cap : 360.13M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 360.13M |
| November 12, 2026 | 345.90M |
| November 11, 2026 | 348.69M |
| November 10, 2026 | 346.41M |
| November 09, 2026 | 349.46M |
| November 06, 2026 | 343.36M |
| November 05, 2026 | 338.53M |
| November 04, 2026 | 331.16M |
| November 03, 2026 | 332.17M |
| November 02, 2026 | 335.48M |
| October 30, 2026 | 331.67M |
| October 29, 2026 | 343.10M |
| October 28, 2026 | 343.10M |
| October 27, 2026 | 333.19M |
| October 26, 2026 | 338.27M |
| October 23, 2026 | 340.31M |
| October 22, 2026 | 346.91M |
| October 21, 2026 | 338.27M |
| October 20, 2026 | 336.75M |
| October 19, 2026 | 336.75M |
| October 16, 2026 | 336.75M |
| October 15, 2026 | 343.86M |
| October 14, 2026 | 339.29M |
| October 13, 2026 | 343.10M |
| October 09, 2026 | 346.91M |
| Date | Value |
|---|---|
| October 08, 2026 | 346.91M |
| October 07, 2026 | 347.17M |
| October 06, 2026 | 352.25M |
| October 05, 2026 | 348.19M |
| October 02, 2026 | 346.91M |
| October 01, 2026 | 346.91M |
| September 30, 2026 | 346.91M |
| September 29, 2026 | 347.93M |
| September 28, 2026 | 346.91M |
| September 25, 2026 | 353.01M |
| September 24, 2026 | 357.33M |
| September 23, 2026 | 362.67M |
| September 22, 2026 | 369.28M |
| September 21, 2026 | 366.48M |
| September 18, 2026 | 372.84M |
| September 17, 2026 | 377.67M |
| September 16, 2026 | 368.77M |
| September 15, 2026 | 370.04M |
| September 14, 2026 | 375.38M |
| September 11, 2026 | 363.43M |
| September 10, 2026 | 360.89M |
| September 09, 2026 | 361.91M |
| September 08, 2026 | 359.62M |
| September 04, 2026 | 364.45M |
| September 03, 2026 | 365.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 116.01M |
| Bausch Health Cos., Inc. | 4.457B |
| BioSyent, Inc. | 201.74M |
| Revive Therapeutics Ltd. | 6.535M |
| Knight Therapeutics, Inc. | 1.185B |
Market Cap Related Metrics
| PE Ratio | 7.700 |
| PS Ratio | 5.356 |
| PEG Ratio | 0.0791 |
| Price to Book Value | 1.721 |
| Price to Free Cash Flow | 11.12 |
| Price | 14.17 |
| Earnings Yield | 12.99% |
| PEGY Ratio | 0.0791 |
| Operating PE Ratio | 13.61 |
| Normalized PE Ratio | 8.057 |